Anaphylaxis to the first dose of mRNA SARS‐CoV‐2 vaccines: Don't give up on the second dose!

Allergy: European Journal of Allergy and Clinical Immunology - Tập 76 Số 9 - Trang 2916-2920 - 2021
Matthew S. Krantz1, Maria A. Bruusgaard‐Mouritsen2, Grace Koo1, Elizabeth J. Phillips3, Cosby A. Stone1, Lene H. Garvey2
1Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA
2Department of Dermatology and Allergy Allergy Clinic Copenhagen University Hospital – Herlev and Gentofte Copenhagen Denmark
3Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Interim Clinical Considerations for Use of mRNA COVID‐19 Vaccines | CDC. Published February 10 2021.https://www.cdc.gov/vaccines/covid‐19/info‐by‐product/clinical‐considerations.html. Accessed February 10 2021.

10.1001/jama.2021.3976

10.1001/jama.2021.1967

10.1186/s13601-018-0215-x

Bruusgaard‐Mouritsen MA, 2021, Optimizing investigation of suspected allergy to polyethylene glycols, J Allergy Clin Immunol, 1

Thông tin
Thông tin xuất bản

Allergy: European Journal of Allergy and Clinical Immunology

Tập 76 Số 9

2916-2920

Thông tin tác giả